Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Structural Biology of the Immune Checkpoint Receptor PD-1 and Its Ligands PD-L1/PD-L2

Published:2017-08 Issue:8 Volume:25 Page:1163-1174
ISSN:0969-2126
Container-title:Structure
language:en
Short-container-title:Structure

Author:

Zak Krzysztof M.,Grudnik Przemyslaw,Magiera Katarzyna,Dömling Alexander,Dubin Grzegorz,Holak Tad A.

Funder

NIH

Kanker Bestrijding

Innovative Medicines Initiative

European Union’s Seventh Framework Programme

EFPIA

European Union's Horizon 2020 research and innovation programme

CoFund ALERT

National Science Center

Jagiellonian University

Ministry of Science and Higher Education

Publisher

Elsevier BV

Subject

Molecular Biology,Structural Biology

Reference50 articles.

1. Molecular mechanisms of T cell co-stimulation and co-inhibition;Chen;Nat. Rev. Immunol.,2013

2. A dimeric structure of PD-L1: functional units or evolutionary relics?;Chen;Protein Cell,2010

3. Structure and interactions of the human programmed cell death 1 receptor;Cheng;J. Biol. Chem.,2013

4. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion;Dong;Nat. Med.,1999

5. Engineered T cells: the promise and challenges of cancer immunotherapy;Fesnak;Nat. Rev. Cancer,2016

Cited by 275 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inducing or enhancing protein-protein interaction to develop drugs: Molecular glues with various biological activity;European Journal of Medicinal Chemistry;2024-11

2. Structural Insights of PD-1/PD-L1 Axis: An In silico Approach;Current Protein & Peptide Science;2024-10

3. Targeting PD-1/PD-L1 in tumor immunotherapy: Mechanisms and interactions with host growth regulatory pathways;Cytokine & Growth Factor Reviews;2024-10

4. A phase III study to access the safety and efficacy of prolgolimab 250 mg fixed dose administered every 3 weeks versus prolgolimab 1 mg/kg every 2 weeks in patients with metastatic melanoma (FLAT);Frontiers in Oncology;2024-09-04

5. Blocking the PD-1 signal transduction by occupying the phosphorylated ITSM recognition site of SHP-2;Science China Life Sciences;2024-08-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3